Next-Generation Neurotechnology Developed by DARPA: Innovative Nanotech Delivered Through Injections
In a recent development, DARPA, the US Defense Advanced Research Projects Agency, is actively working on a groundbreaking project known as the Next Generation Nonsurgical Neurotechnology (N3) program. This initiative aims to revolutionise neurotechnology by enabling the reading and interpretation of brain signals without invasive surgery, using non-invasive methods such as EEG and potentially others involving electromagnetic fields [1][3][4].
The N3 program primarily focuses on developing non-surgical brain-machine interfaces for interpreting brain activity. While the technology is promising, it is essential to clarify that current public information primarily emphasises non-surgical methods like EEG sensors on the scalp rather than internal nanoscale devices delivered through injections or nasal routes [1][3].
Research involving magnetism and electromagnetic fields is crucial in the development of brain-machine interfaces at DARPA. However, this research is generally targeted at external control or sensing rather than direct remote control of nanotechnology inside the body [4].
Recent speculation has emerged about DARPA controlling internal nanotechnology in humans remotely via injections or nasal administration, combined with remote actuation via ultrasound, magnetic fields, electric fields, or RF. However, there is no publicly available verified evidence supporting these claims [1][3][4].
The DARPA document titled "Next-Generation Non-Surgical Neurotechnology" provides insights into technology for "technological possession" that can be inoculated in humans via injections, nasal administration, and controlled from a distance using ultrasound, magnetic fields, electric fields, and RF. The document also states that successful experiments have been conducted on rats and primates [2].
The goal of comments on this article is to gain additional truth about this fascinating and potentially transformative technology. Readers are encouraged to share their insights, provide clarification, or offer truthful rebuttals to any misconceptions. However, it is essential to maintain a respectful and fact-based discussion.
The DARPA document was published on March 23rd, 2018, and can be accessed at [https://x.com/Inversionism/status/1831302548411601142]. The article can be found at [https://t.me/therealcanadianpatriots/148758].
It is important to note that the article does not provide any information about who is moderating the comments or how they will be managed. Similarly, there are no specific requirements or guidelines for submitting comments.
The technology involved in the N3 program includes self-assembly inside the body, and the nanotransducers must be delivered in a minimally invasive manner, which may include ingestion, injection, or nasal administration.
As this technology continues to evolve, it is crucial to stay informed and engage in open, respectful discussions about its potential implications. Let's continue to explore and understand this fascinating field together!
[1] [https://www.darpa.mil/program/next-generation-nonsurgical-neurotechnology-n3] [2] [https://x.com/Inversionism/status/1831302548411601142] [3] [https://www.researchgate.net/publication/326895767_Next-Generation_Non-Surgical_Neurotechnology] [4] [https://www.nature.com/articles/s41598-018-22830-y]
- The article discusses the ongoing development of the DARPA N3 program, which is based on both science and technology, with a focus on creating non-invasive brain-machine interfaces.
- Despite speculations about remote control of internal nanotechnology, there's currently no publicly available verified evidence supporting these claims, and the technology primarily involves self-assembly and minimally invasive delivery methods.
